All lobbying filings

ARDELYX, INC.

Lobbying for ARDELYX, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $540,000.00 expenses · posted Jul 18, 2025

Official filing document

Bills named in this filing 2

HR 5074
Kidney PATIENT Act of 2023
S 4510
Kidney PATIENT Act of 2024

Lobbying activity 2

Health Issues

H.R.5074, S.4510, Kidney Patient Act, Kidney Health Equity. Access to Innovative Kidney Treatments.

Medicare/Medicaid

Medicaid rebate, most favored nation drug pricing. Increase Access to Innovation for People with Kidney Failure. Support Medicare Part D access to phosphorus-lowering medications.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.